The CELMoD Shift: Translating Protein Degradation Science Into Practice-Changing Myeloma Care
December 11, 2026 New Orleans, Louisiana
Surgery vs Definitive RT for Pharyngeal and Laryngeal SCC
Can PCE Induction Improve Outcomes in Advanced HNSCC?
Key Drivers of Radioresistance in Head and Neck Squamous Cell Carcinoma
Heath Skinner, MD, PhD
Treatment Order and Survival in Recurrent or Metastatic Head and Neck Cancer
Ryan Quigley
From Radioresistance Research to Trials in Head and Neck Squamous Cell Carcinoma
The Search for Radioresistance Biomarkers in Head and Neck Squamous Cell Carcinoma
Can MRI Predict Active Surveillance Failure in Desmoid-Type Fibromatosis?
Test Before You Treat: Biomarkers That Shape CLL Care
Cryoablation Offers Local Control for Extra-Abdominal Desmoid Tumors
How Cancer Worry Influences Smoking Cessation
Hermine Poghosyan, PhD
CAR T-Cell Therapy in R/R LBCL: Overcoming Barriers to Referral and Completion
Alexandria May, PharmD, BCPS
Tara Graff, DO, MS
Making the Most of Biomarker Testing in NSCLC
Steve Jackson, PharmD
Angel Qin, MD
Safety Considerations and AE Monitoring for Trial Participation With Combination Regimens
Timothy F. Burns, MD, PhD
KRAS G12C Biology: Why Is This Mutation Different?
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
Gerard A. Silvestri MD, MS
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.